We have been sharing a lot of information about native GLP-1 and GLP-1 analogs, and how these compounds work to control glucose levels in our patients. Lately there has been a lot of press concerning the possible cardiovascular benefits of using these analogs in our patients. We’ve been able to …

Melanie Sulistio, MD, Curtis Carothers, MD, Mandeep Mange, BS, Mike Lujan, BS, Rene Ofiveros, MD, and Robert Chilton, DO Cardiovascular disease is a leading cause of death in the United States and across the world, and better therapies are constantly being sought to improve patient outcomes. Recent studies have brought …

When using a U-100 insulin syringe or a tuberculin syringe, use this handy U-500 Conversion Chart. Humulin U-500 Conversion Chart Mar 2011

Sanofi iBGStar™ iPhone Blood Glucose Monitor Sanofi has received FDA approval to market and sell the first blood glucose monitor that attaches to the iPhone and iPod Touch, converting it into a glucose meter. The readings are automatically downloaded to the iBGStar App for logging. The app can also be …

FDA Approves Sanofi’s iBGStar iPhone Glucose Monitor See Product of the Week below.

Adverse drug events (ADEs) cause an estimated 100,000 emergency hospitalizations for seniors each year, yet two thirds involve just a handful of anticoagulants and diabetes medications. A study by researchers from the US CDC, singles out 4 drugs and drug classes: warfarin, oral antiplatelet medications, insulins, and oral hypoglycemic agents. …

According to a new study which reviewed 84 brands of children’s breakfast cereals, two thirds of them contain more added sugar by weight than is recommended by the US government. The Environmental Working Group analysis found that only 1 in 4 children’s cereals meet all of the group’s recommendations, which …

An estimated 9.3 million American adults lost health insurance coverage as a result of increased unemployment during the recession of 2007-09. The newly published study found that roughly nine times as many Americans lost health insurance coverage in the recession of 2007-09 as in the previous recession of 2001. It …

Sanofi presented fresh data which it says reinforces the safety profile of Lantus, hours after dismissing claims in a study that using the diabetes treatment more than doubled the risk of developing cancer….

A combination of two insulins reduced abnormally low blood sugar in diabetes patients….